Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

BIOTRONIK Neuro will unveil new data from the BENEFIT-03 clinical study at the North American Neuromodulation Society (NANS) 2025 Annual Meeting. The findings highlight the transformative potential of ...

In a statement, SAAS said it had been recently advised of a temporary supply issue with pain medications intranasal fentanyl and inhaled methoxyflurane, which is also known as the green whistle.

Paul Howe, chief commercial officer at Protega, discusses efforts to combine high tech solutions with pain-management medications. The opioid crisis in the United States continues to cause chaos and ...

Accepting NEW Clients (ages 18-65) as of 1/24/25 for Medication Management (I am not taking clients for therapy). Appointments are available in 2 weeks. Complete the Patient Inquiry Form on my ...

For most adults, a resting heart rate range of 60 to 100 beats per minute (bpm) is typical: However, a number of factors—including physical activity levels, stress and medication—can impact ...

She found the gummies did help with pain without impacting her cognition, making these a better option than products that contain THC, as well as muscle relaxers or migraine medication.